MultiplexDX Inc.

About:

Developing products for precision medicine: affordable, reliable, specific, quantifiable, and accurate precision diagnostic technology.

Website: http://www.multiplexdx.com

Twitter/X: multiplexdx

Top Investors: Crowdberry, Neulogy Ventures, IPA4SME, Ronald Cook

Description:

MultiplexDX is a biotech diagnostics company, developing accurate, specific, quantifiable, and affordable diagnostic tests. It aims to provide effective and successful treatment of tumors and prevent cancer. To achieve this, the company is in the phase of developing a new visualization technology combining the approach of molecular biology and histopathological methods. This technology has an ambition to surpass the limitations of existing medical diagnostic and prognostic methods and to take a key role in this fast-changing market. MultiplexDX operates from Kosice, Slovakia and Maryland, US and is currently serving first clients on both European and US markets.

Total Funding Amount:

1.2M EUR

Estimated Revenue Range:

Less than $1M

Headquarters Location:

Gaithersburg, Maryland, United States

Founded Date:

2015-11-30

Contact Email:

info(AT)multiplexdx.com

Founders:

Pavol Cekan, Vladimir Wolf

Number of Employees:

1-10

Last Funding Date:

2019-09-24

IPO Status:

Private

Industries:

© 2025 bioDAO.ai